Inhibition of Oligopeptide MTRV on Poly I:C-induced Embryo Resorption

ZHONG Yan-min,LIN Yi,LI Li-ping,Nisar Khan,DI Jing-fang,ZENG Shan,Robbert Benner
DOI: https://doi.org/10.3969/j.issn.1001-2478.2007.02.012
2007-01-01
Abstract:To determine whether HCG-derived oligopeptide MTRV(Met-Thr-Arg-Val) can inhibit poly I:C-induced embryo resorption and the possible immunological mechanisms,poly I:C-induced embryo resorption model was established by peritoneal injection of poly I:C to female BALB/c×C57BL/6 mating combination.The administration of MTRV was performed at several time points during pregnancy in the poly I:C-induced female mice.The fetal resorption rate(RR) were measured on day 9.5 and day 13.5 of gestation.Meanwhile,the percentages of immunocompetent cell subsets,together with the expression of early T cell activation marker CD25,costimulatory molecule CD86,and the intracellular Th1-promoting cytokine IL-12,were tested both in placenta(PL) and peripheral blood(PB) using four-color flow cytometry.It was demonstrated that the multiple administrations of MTRV could not change the poly I:C-induced increase of the relative number of immunocompetent cells.However,it could abrogate the poly I:C-induced increase of the percentage of placental CD45+IL-12+ cells,and inhibit poly I:C-induced increase of embryo-resorption.It suggests that HCG-derived oligopeptide MTRV may change the functional status of immunocompetent cells at the feto-maternal interface and subsequently inhibit poly I:C-induced embryo resorption.
What problem does this paper attempt to address?